HEPATIC PARENCHYMAL CHANGES AFTER THE INTRAARTERIAL INJECTION OF LIPIODOL IN TUMOR-BEARING RABBITS

被引:8
作者
AKASHI, Y [1 ]
KOREEDA, C [1 ]
MIZUNO, T [1 ]
INOUE, K [1 ]
KAWA, SKH [1 ]
TANAKA, Y [1 ]
机构
[1] KANSAI MED UNIV,DEPT RADIOL,MORIGUCHI,OSAKA 570,JAPAN
关键词
INTRAARTERIAL INJECTION; LIPIODOL; LIVER; VX2-TUMOR;
D O I
10.1097/00004424-199302000-00009
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
RATIONALE AND OBJECTIVES. The influence of lipiodol injection on hepatic morphology and function was investigated in 119 rabbits with hepatic VX2 tumors. METHODS. The rabbits were divided into the following three groups, according to the materials injected via the proper hepatic artery: group 1 received doxorubicin (Adriamycin [ADM]); group 2 received lipiodol (LPD); and group 3 received LPD plus ADM. Groups 2 and 3 were each divided into three subgroups, according to the dose of LPD injected (0.3, 0.6, and 1.2 mL). Non-tumorous regions in the tumor-bearing lobe and the tumor-free lobe were examined histologically; low-kilovolt x-ray studies and computed tomography (CT) also were performed in 84 rabbits. Liver function tests were performed in 35 rabbits. RESULTS. Elevation of the serum aminotransferase levels was observed after the administration of LPD. Hepatocellular degeneration was marked in the tumor-free lobe, but was much more severe in the tumor-bearing lobe in groups 2 and 3. The degree of degeneration depended on the dose of LPD. Both low-kilovolt x-ray studies and CT showed the heavy accumulation of LPD in the tumor-bearing lobe. CONCLUSIONS. The current study shows that the histologic and functional adverse effects of oily chemoembolization depend on the dose of LPD administered to the liver.
引用
收藏
页码:128 / 132
页数:5
相关论文
共 13 条
[1]   COMPARISON OF HEPATIC VX2-CARCINOMAS AFTER INTRA-ARTERIAL, INTRAPORTAL AND INTRAPARENCHYMAL TUMOR-CELL INJECTION - ANGIOGRAPHIC AND COMPUTED TOMOGRAPHIC STUDY IN THE RABBIT [J].
BURGENER, FA ;
VIOLANTE, MR .
INVESTIGATIVE RADIOLOGY, 1979, 14 (05) :410-414
[2]  
HIRAI K, 1983, ACTA HEPATOL JPN, V24, P1012
[3]  
IWAI K, 1984, CANCER RES, V44, P2115
[4]   A 5-YEAR EXPERIENCE OF LIPIODOLIZATION - SELECTIVE REGIONAL CHEMOTHERAPY FOR 200 PATIENTS WITH HEPATOCELLULAR-CARCINOMA [J].
KANEMATSU, T ;
FURUTA, T ;
TAKENAKA, K ;
MATSUMATA, T ;
YOSHIDA, Y ;
NISHIZAKI, T ;
HASUO, K ;
SUGIMACHI, K .
HEPATOLOGY, 1989, 10 (01) :98-102
[5]   TREATMENT OF HEPATOCELLULAR-CARCINOMA BY TRANSCATHETER ARTERIAL EMBOLIZATION COMBINED WITH INTRAARTERIAL INFUSION OF A MIXTURE OF CISPLATIN AND ETHIODIZED OIL [J].
KASUGAI, H ;
KOJIMA, J ;
TATSUTA, M ;
OKUDA, S ;
SASAKI, Y ;
IMAOKA, S ;
FUJITA, M ;
ISHIGURO, S .
GASTROENTEROLOGY, 1989, 97 (04) :965-971
[6]   EFFECT OF ARTERIAL ADMINISTRATION OF HIGH-MOLECULAR-WEIGHT ANTI-CANCER AGENT SMANCS WITH LIPID LYMPHOGRAPHIC AGENT ON HEPATOMA - A PRELIMINARY-REPORT [J].
KONNO, T ;
MAEDA, H ;
IWAI, K ;
TASHIRO, S ;
MAKI, S ;
MORINAGA, T ;
MOCHINAGA, M ;
HIRAOKA, T ;
YOKOYAMA, I .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (08) :1053-&
[7]  
KONNO T, 1984, CANCER, V54, P2367, DOI 10.1002/1097-0142(19841201)54:11<2367::AID-CNCR2820541111>3.0.CO
[8]  
2-F
[9]  
KOREEDA C, 1990, EXPT STUDIES USE LIP, P636
[10]   TRANSCATHETER OILY CHEMOEMBOLIZATION OF HEPATOCELLULAR-CARCINOMA [J].
NAKAMURA, H ;
HASHIMOTO, T ;
OI, H ;
SAWADA, S .
RADIOLOGY, 1989, 170 (03) :783-786